At the European Association for the Study of Diabetes (EASD) Annual Meeting 2026, three RCTs examined lifestyle interventions for metabolic health, focusing on when to eat, environmental temperature, and digital delivery.
Article Key Points
- 12-week early TRE RCT (n=29): skeletal muscle insulin sensitivity improved (P=0.042) without weight or diet change
- 6-week daily cold exposure RCT (n=47): body weight -1.6 kg via fat mass loss (-1.5 kg); lean mass preserved
- 90-day digital lifestyle intervention in T2D (n=149): HbA1c -1.46%, weight -1.49 kg vs standard care
- High-adherence (>35%) subgroups showed greater benefit: HbA1c -1.7% vs -0.8%, FPG -25.2 vs -3.1 mg/dL
- Evidence status: conference abstracts; full results have not yet been peer-reviewed
12-Week Early Time-Restricted Eating: Improved Skeletal Muscle Insulin Sensitivity Without Weight Change
Study design: Randomized controlled trial in adults with overweight or obesity and prediabetes or insulin resistance. Participants were randomized to early time-restricted eating (TRE) with a 9-hour eating window (08:00-17:00, n=14) or to a control arm with a 14-hour eating window (08:00-22:00, n=15) for 12 weeks. Multi-organ insulin sensitivity was assessed using a two-stage hyperinsulinemic-euglycemic clamp.
Results: In the TRE arm, the eating window shortened from 13.6 hours to 9.3 hours (P<0.001); the control arm showed no significant change. Diet composition and body weight did not change significantly in either arm. Skeletal muscle insulin sensitivity improved significantly in the TRE arm (P=0.042); adipose tissue insulin resistance showed a downward trend (P=0.06); hepatic insulin sensitivity did not improve. Self-rated quality of life improved significantly in the TRE arm (P=0.047).
These findings suggest that, in adults with overweight or obesity and prediabetes or insulin resistance, early TRE can improve skeletal muscle insulin sensitivity, with adipose tissue insulin resistance trending toward improvement, and enhance self-rated quality of life.
6-Week Daily Cold Exposure: Weight Loss Driven by Fat Mass Reduction, No Loss of Lean Mass
Study design: Randomized controlled trial in 47 adults with overweight or obesity (BMI 25-35 kg/m²), randomized 1:1 to a cold exposure arm (n=24) or control (n=23). The cold exposure arm wore a cooling vest and waist belt equipped with phase-change cooling pads at 15°C for 2 hours each morning for 6 weeks.
Results: Compared with control, the cold exposure arm lost 1.6 kg in body weight (P<0.001) and 0.5 kg/m² in BMI (P<0.001); fat mass fell by 1.5 kg (P=0.007) while lean mass showed no significant change (P=0.860). During acute cold stimulation, carbohydrate oxidation was enhanced in the cold exposure arm (P=0.019), and cold-induced resting energy expenditure trended higher (P=0.058). Liver fat, blood glucose, and inflammatory markers did not change significantly.
These findings suggest that, in overweight or obese participants, daily cold exposure lowers body weight primarily by reducing fat mass, with lean mass preserved. The absence of changes in hepatic steatosis, lipid and glucose metabolism, and inflammatory markers may reflect the modest fat-mass reduction over the 6-week intervention.
90-Day Digital Lifestyle Intervention: Glycemic and Anthropometric Improvements with Adherence-Dependent Benefit
Study design: Randomized controlled trial in 149 adults with type 2 diabetes (T2D), randomized to a 90-day structured digital lifestyle intervention plus standard care (n=87) or standard care alone (n=62). The intervention arm was further stratified by adherence into high-adherence (>35% adherence rate) and low-adherence (<35% adherence rate) subgroups.
Results: Compared with control, HbA1c fell by 1.46% (P<0.001), fasting plasma glucose (FPG) by 19.87 mg/dL (P<0.001), BMI by 0.55 kg/m² (P<0.001), and body weight by 1.49 kg (P<0.001) in the intervention arm; the control arm showed no glycemic improvement and only minor anthropometric gains. Subgroup analysis showed greater benefit in high-adherence than low-adherence participants: HbA1c reduction 1.7% vs 0.8%, FPG reduction 25.2 vs 3.1 mg/dL, BMI reduction 0.6 vs 0.5 kg/m², and weight reduction 1.6 vs 1.4 kg.
These findings suggest that, in T2D patients, digital lifestyle intervention improves glycemic and anthropometric outcomes versus standard care, with greater benefit among high-adherence participants. The investigators noted the benefit may derive from high-frequency, empathetic one-on-one digital coaching that continuously reinforces adherence behavior.
Conclusion
Three studies extended the range of lifestyle intervention formats, from time-restricted eating and cold exposure to digital tools. For clinicians, these findings offer new directions for personalized metabolic management, while specific regimens should still be selected based on individual patient circumstances and delivered under physician supervision.